hengrui glp-1 Hengrui, Kailera's pill posts encouraging efficacy but high side effect rates in late-stage China trials China's Hengrui Grants Global Rights

We prescribe the same FDA-approved weight loss medications, but through their direct pharmacy options, to help you save money

The state obesity drug coverage landscape will continue to evolve as states respond to the recent announcement of the BALANCE model (see Box 1) and as states contend with budget challenges and the federal Medicaid spending cuts in the 2025 reconciliation law

Real users consistently report rebound hunger and no sustained weight loss

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs)along with the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1RA tirzepatideare widely acknowledged for their efficacy in managing both type 2 diabetes mellitus and obesity, with expanding indications in cardiometabolic risk reduction

B., Saltiel, M

Gastroenterology 132, 21312157, doi: 10.1053/j.gastro.2007.03.054 (2007)